Phathom Pharmaceuticals I... (PHAT)
NASDAQ: PHAT
· Real-Time Price · USD
10.26
-0.21 (-2.01%)
At close: Aug 15, 2025, 3:59 PM
10.24
-0.15%
After-hours: Aug 15, 2025, 06:01 PM EDT
Phathom Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 114.04M | 81.86M | 55.25M | 26.27M | 9.92M | 2.59M | 682K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 14.93M | 11.27M | 7.97M | 3.94M | 1.7M | 447K | 21K | 412K | 466K | 492K | 620K | 587K | 542K | 524K | 521K | 386K | 256K | 125K |
Gross Profit | 99.11M | 70.59M | 47.28M | 22.34M | 8.22M | 2.15M | 661K | -412K | -466K | -492K | -620K | -587K | -542K | -524K | -521K | -386K | -256K | -125K |
Operating Income | -269M | -286.38M | -277.47M | -287.93M | -252.79M | -207.19M | -167.31M | -144.08M | -150.95M | -164.61M | -172.44M | -158.84M | -149.45M | -139.4M | -135.08M | -154.48M | -154.17M | -138.87M |
Interest Income | 11.65M | 13.48M | 15.16M | 15M | 14.01M | 10.73M | 7.88M | 5.81M | 3.82M | 3.58M | 2.13M | 851K | 133K | 34K | 41K | 51K | 58K | 227K |
Pretax Income | -330.15M | -345.79M | -334.33M | -339.44M | -297.11M | -246.63M | -201.59M | -177.07M | -184.92M | -194.87M | -197.72M | -178.5M | -164.07M | -149.71M | -143.88M | -161.78M | -159.22M | -143.77M |
Net Income | -330.15M | -345.79M | -334.33M | -339.44M | -297.11M | -246.63M | -201.59M | -185.47M | -201.88M | -211.84M | -217.45M | -189.82M | -166.83M | -152.46M | -143.88M | -161.78M | -159.22M | -143.77M |
Selling & General & Admin | 332.57M | 323.13M | 290.66M | 270.98M | 218.27M | 161.34M | 117.93M | 91.63M | 91.74M | 99.35M | 101M | 89.79M | 82.81M | 69.98M | 62.74M | 54.04M | 44.57M | 36.01M |
Research & Development | 35.54M | 33.84M | 34.08M | 38.89M | 42.46M | 47.85M | 49.9M | 52.45M | 59.21M | 65.26M | 71.44M | 69.05M | 66.64M | 69.42M | 72.34M | 100.44M | 109.6M | 102.86M |
Other Expenses | n/a | -6K | -49K | -63K | -260K | -251K | -208K | -283K | -97K | -102K | -109K | -37K | -26K | -14K | -8K | 7K | 3K | -7K |
Operating Expenses | 368.11M | 356.96M | 324.75M | 309.87M | 260.74M | 209.19M | 167.83M | 144.08M | 150.95M | 164.61M | 172.44M | 158.84M | 149.45M | 139.4M | 135.08M | 154.48M | 154.17M | 138.87M |
Interest Expense | 72.67M | 72.91M | 72.01M | 66.44M | 58.07M | 49.92M | 41.97M | 38.54M | 37.71M | 33.76M | 27.31M | 20.48M | 12.69M | 8.28M | 6.79M | 5.31M | 5.11M | 5.12M |
Selling & Marketing Expenses | n/a | n/a | n/a | -3.93M | -3.93M | -3.93M | -3.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 383.04M | 368.24M | 332.72M | 314.19M | 262.71M | 209.78M | 167.99M | 144.08M | 150.95M | 164.61M | 172.44M | 158.84M | 149.45M | 139.4M | 135.08M | 154.48M | 154.17M | 138.87M |
Income Tax Expense | n/a | n/a | 170.72K | 170.72K | 170.72K | 170.72K | n/a | 8.4M | 16.97M | 16.97M | 19.73M | 11.32M | 2.76M | 2.76M | n/a | n/a | n/a | 182K |
Shares Outstanding (Basic) | 72.47M | 71.97M | 71.05M | 64.63M | 58.56M | 58.37M | 57.29M | 56.78M | 48.5M | 42.35M | 41.31M | 38.82M | 38.27M | 38.04M | 37.76M | 37.3M | 36.64M | 36.3M |
Shares Outstanding (Diluted) | 72.47M | 71.97M | 71.05M | 64.63M | 58.56M | 58.37M | 57.29M | 56.78M | 48.5M | 42.35M | 41.31M | 38.82M | 38.27M | 38.04M | 37.76M | 37.3M | 36.64M | 36.3M |
EPS (Basic) | -4.73 | -5.24 | -5.35 | -5.69 | -5.13 | -4.41 | -3.88 | -4.03 | -4.81 | -5.3 | -5.55 | -4.96 | -4.4 | -4.07 | -3.89 | -4.52 | -4.56 | -4.2 |
EPS (Diluted) | -4.73 | -5.24 | -5.35 | -5.69 | -5.13 | -4.41 | -3.88 | -4.03 | -4.81 | -5.3 | -5.55 | -4.96 | -4.4 | -4.07 | -3.89 | -4.52 | -4.56 | -4.2 |
EBITDA | -259.55M | -274.92M | -261.52M | -272.21M | -238.33M | -196.07M | -159.05M | -137.97M | -146.59M | -160.47M | -169.8M | -157.44M | -150.84M | -140.91M | -136.57M | -155.99M | -153.68M | -138.27M |
EBIT | -260.11M | -275.5M | -262.32M | -273M | -239.04M | -196.71M | -159.62M | -138.53M | -147.21M | -161.11M | -170.42M | -158.02M | -151.39M | -141.43M | -137.09M | -156.47M | -154.11M | -138.66M |
Depreciation & Amortization | 733K | 758K | 795K | 787K | 717K | 643K | 575K | 558K | 612K | 638K | 620K | 587K | 542K | 524K | 521K | 492K | 450K | 396K |